Skip to main content
SpringerLink
Log in

The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Several immunological in vitro tests were performed on peripheral blood mononuclear cells of patients with adenocarcinoma of the prostate, stages A, B, C, D. The cytotoxicity of effector natural killer cells towards K-562 targets decreased with increasing disease spread, while their percentage was not significantly changed. The proportion of CD4 (helper/inducer) cells tended to fall with tumor advance, but the proportion of CD8 (suppressor/cytotoxic) cells remained almost constant. Secretion of interleukin-2 from peripheral blood mononuclear cells was diminished with disease progression. Pretreatment of a patient's lymphocytes with cimetidine (antagonist of H-2-bearing suppressor T cells) or indomethacin (inhibitor of prostaglandin synthesis) enhanced natural killer activity.

Our data point to the existence of abberant immune functions in early stages of carcinoma of the prostate and to aggravation of these immune abnormalities in advanced disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allavena P, Introna M, Mangioni C, Mantovani A (1981) Inhibition of NK activity by tumor associated lymphoid cells from ascitic ovarian carcinomas. J Natl Cancer Inst 67:379

    Google Scholar 

  2. Balch CM, Dougherty PA, Tilden AB (1982) Executive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients. Ann Surg 196:645

    Google Scholar 

  3. Bankhurst AD (1982) The modulation of human NK cell activity by prostaglandins. J Clin Lab Immunol 7:85

    Google Scholar 

  4. Barlozzari T, Reynolds CW, Herberman RB (1983) In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in antiasialo GM1-treated rats. J Immunol 131:1024

    Google Scholar 

  5. Böyum A (1968) Separation of leucocytes from blood and bone marrow. Scand J Clin Invest 21 (suppl) 97:77

    Google Scholar 

  6. Braun DP, Harris JE (1981) Relationship of leucocyte numbers, immunoregulatory cell function and PHA responsiveness in cancer patients. J Natl Cancer Inst 67:809

    Google Scholar 

  7. Braun DP, Harris JE, Rubinstein M (1984) Relationship of arachidonic acid metabolism in indomethacin sensitive immunoregulatory function and lymphocyte PGE sensitivity in PBMC of disseminated solid tumor cancer patients. J Immunopharmacol 6:227

    Google Scholar 

  8. De Baer KP, Braun DP, Harris JE (1982) Natural cytotoxicity and antibody dependent cytotoxicity in solid tumor cancer patients. Regulation by adherent cells. Clin Immunol Immunopathol 23:133

    Google Scholar 

  9. Domzig W, Stadler BM, Herberman RB (1983) Interleukin-2 dependence of human NK cell activity. J Immunol 130:1970

    Google Scholar 

  10. Flodgren P, Sjogren O (1985) Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon. Cancer Immunol Immunother 19:28

    Google Scholar 

  11. Flodgren P, Bongstrom S, Jansson P, Lindstrom C, Sjogren HO (1983) Metastatic malignant melanoma: regression induced by combined treatment with interferon HUIFN-α (αe) and cimetidine. Int J Cancer 32:657

    Google Scholar 

  12. Gerson JM, Varesio L, Herberman RB (1981) Systemic and in situ NK activities in mice bearing progressively growing murine sarcoma virus induced tumors. Int J Cancer 27:243

    Google Scholar 

  13. Gillis S, Feanin M, Ou W, Smith KA (1980) T cell growth: parameters of production and quantitative microassay for activity. J Immunol 120:2027

    Google Scholar 

  14. Goodwin JS, Messner RP, Peake GT (1980) Prostaglandin suppression of mitogen stimulated dependent restoration of local graft versus host reaction among cells from cancer patients. J Natl Cancer Inst 65:317

    Google Scholar 

  15. Haller O, Hannson M, Kiessling R, Wigzell H (1977) Nonconventional NK cells may play a decisive role in providing resistance against syngeneic tumor cells in vivo. Nature 270:609

    Google Scholar 

  16. Han T, Takita H (1980) Indomethacin mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients. Cancer 46:2416

    Google Scholar 

  17. Harris JE, DeBaer KP, Vahey AL et al. (1982) The measurement of leucocyte subsets in the peripheral blood of cancer patients with solid tumors using monoclonal antibody regents. Med Pediat Oncol 10:185

    Google Scholar 

  18. Herberman RB, Munn ME, Lavnin DH (1975) Natural cytotoxicity activity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16:216

    Google Scholar 

  19. Herr HW (1980) Suppressor cells in immunodepressed bladder and prostate cancer patients. J Urol 123:635

    Google Scholar 

  20. Herr HW (1981) Adherent suppressor cells in the blood of patients with bladder cancer. J Urol 126:457

    Google Scholar 

  21. Hinai U, Hill NO, Motoo Y, Osther K (1985) Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production. Acta Pathol Microbiol Immunol Scand 93:153

    Google Scholar 

  22. Jewett NJ (1975) The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 2:105

    Google Scholar 

  23. Karavodin LM, Giuliano AE, Golub SH (1981) T lymphocyte subsets in patients with malignant melanoma. Cancer Immunol Immunother 11:251

    Google Scholar 

  24. Kasai JC, Leclerc JC, McVay-Bodreau L, Shen FW, Cantor H (1979) Direct evidence that NK cells in non immune spleen cell populations prevent tumor growth in vivo. J Exp Med 149:1260

    Google Scholar 

  25. Lang NP, Ortaldo JR, Bonnard GP, Herberman RB (1982) Interferon and prostaglandins: effects on human natural and lectin induced cytotoxicity. J Natl Cancer Inst 69:339

    Google Scholar 

  26. Miyaska N, Darnell B, Baron S, Talal N (1984) Interleukin-2 enhances natural killing of normal lymphocytes. Cell Immunol 84:154

    Google Scholar 

  27. Ogden BE, Hill HR (1980) Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors. Immunology 41:107

    Google Scholar 

  28. Ortaldo JR, Herberman RB (1984) Heterogeneity of NK cells. Annu Rev Immunol 2:359

    Google Scholar 

  29. Osband ME, Hamilton D, Shen YJM, Cohen E, Shlesinger M, Lavin P, Brown A, MacCaffrey R (1981) Successful tumour immunotherapy with cimetidine in mice. Lancet i:636

    Google Scholar 

  30. Pollack SB, Hallenbeck LA (1982) In vivo reduction of NK activity with anti NK1 serum: direct evidence of NK cells in tumor clearance. Int J Cancer 29:203

    Google Scholar 

  31. Pross HF, Baines MG (1976) Spontaneous human lymphocyte mediated cytotoxicity against tumor target cells. I. The effect of malignant disease. Int J Cancer 18:593

    Google Scholar 

  32. Rocklin RE, Breand J, Gupta S, Good RA, Melman KL (1980) Characterization of the human blood lymphocytes that produce a histamine induced suppressor factor. Cell Immunol 51:226

    Google Scholar 

  33. Ruiz-Arguelles A, Serrogy HB, Ritts RE Jr (1982) In vitro effect of cimetidine on human cell mediated cytotoxicity. I. Inhibition of NK cell activity. Cell Immunol 69:1

    Google Scholar 

  34. Sahasnabudha DM, McCune CS, O'Donnell RW, Henshaw EC (1987) Inhibition of suppressor T lymphocytes by cimetidine. J Immunol 138:2760

    Google Scholar 

  35. Steinhauser EH, Doyle AT, Reed J, Kadish AN (1982) Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. J Immunol 129:2256

    Google Scholar 

  36. Tutton PJM, Barkla DH (1983) Comparison of the tumor inhibitory effects of three histamine H-2 receptor antagonists. Cancer Res 3:7

    Google Scholar 

  37. Von Raenn J, Harris JE, Braun DP (1987) Suppressor cell function in solid tumor cancer patients. J Clin Oncol 5:150

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunology Research Unit, Lady Davis Carmel Hospital, 7 Michael Street, 34362, Haifa, Israel

    Nitza Lahat (Head)

  2. Northern Israel Oncology Center, Rambam Medical Center, Haifa, Israel

    Beny Alexander

  3. Department of Urology, Rambam Medical Center, Haifa, Israel

    Richter Dan Levin & Boaz Moskovitz

Authors
  1. Nitza Lahat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beny Alexander
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richter Dan Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Boaz Moskovitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lahat, N., Alexander, B., Dan Levin, R. et al. The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate. Cancer Immunol Immunother 28, 208–212 (1989). https://doi.org/10.1007/BF00204990

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00204990

Keywords

Search

Navigation